๐ŸงฌTidera Health

Tidera provides educational trial discovery tools and does not provide medical advice or determine eligibility. Always discuss options with your care team.

Condition Guides9 min readICD-10: C43

Melanoma Clinical Trials: Immunotherapy, Targeted Therapy, and Adjuvant Studies

By Tidera Health Editorial Teamยท

Melanoma has been transformed by immunotherapy. Here's what's in clinical trials now โ€” and who qualifies for cutting-edge combination approaches.

About this article: Educational and informational only. Does not constitute medical advice or eligibility guidance. Always discuss clinical trial options with your care team. Verify current trial status at ClinicalTrials.gov.

What You Need to Know

A guide to melanoma clinical trials in 2025 โ€” checkpoint inhibitor combinations, BRAF/MEK targeted therapy trials, neoadjuvant studies, and uveal melanoma trials.

Find recruiting trials for your condition

Search ClinicalTrials.gov in real time โ€” matched to your profile, explained in plain English. Free, no account required.

Start Free Search โ†’

How Tidera Health Can Help

Tidera Health searches ClinicalTrials.gov in real time and uses AI to explain which trials may be relevant to your condition, age, location, and treatment history. It's free, requires no account, and stores no health data.

Enter your condition and location to see currently recruiting trials matched to your profile โ€” with plain-English eligibility explanations and questions to ask the research coordinator.

Topics

melanoma clinical trialsmelanoma immunotherapy trialBRAF trial melanomacheckpoint inhibitor melanoma

Find recruiting trials for your condition

Enter your condition, age, and location. We search ClinicalTrials.gov in real time and explain each trial in plain English. Free, no account required.